ZA766620B - New 6-aryl-s-triazolo(4,3-a)-pyrido(2,3-f)-1,4-diazepines their preparations and their use - Google Patents

New 6-aryl-s-triazolo(4,3-a)-pyrido(2,3-f)-1,4-diazepines their preparations and their use

Info

Publication number
ZA766620B
ZA766620B ZA766620A ZA766620A ZA766620B ZA 766620 B ZA766620 B ZA 766620B ZA 766620 A ZA766620 A ZA 766620A ZA 766620 A ZA766620 A ZA 766620A ZA 766620 B ZA766620 B ZA 766620B
Authority
ZA
South Africa
Prior art keywords
diazepines
triazolo
pyrido
preparations
aryl
Prior art date
Application number
ZA766620A
Other languages
English (en)
Inventor
N Schulmeyer
V Jakovley
Bebenburg W Von
Original Assignee
Degussa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Degussa filed Critical Degussa
Publication of ZA766620B publication Critical patent/ZA766620B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/64One oxygen atom attached in position 2 or 6
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/70Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA766620A 1975-11-04 1976-11-04 New 6-aryl-s-triazolo(4,3-a)-pyrido(2,3-f)-1,4-diazepines their preparations and their use ZA766620B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT837275A AT350056B (de) 1975-11-04 1975-11-04 Verfahren zur herstellung von neuen pyrido- (2,3-f)-(1,4)-diazepinen, deren optischen isomeren und salzen

Publications (1)

Publication Number Publication Date
ZA766620B true ZA766620B (en) 1977-12-28

Family

ID=3604891

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA766620A ZA766620B (en) 1975-11-04 1976-11-04 New 6-aryl-s-triazolo(4,3-a)-pyrido(2,3-f)-1,4-diazepines their preparations and their use

Country Status (30)

Country Link
US (1) US4110455A (fi)
JP (1) JPS5831351B2 (fi)
AR (3) AR217814A1 (fi)
AT (1) AT350056B (fi)
AU (1) AU504228B2 (fi)
BE (1) BE847952A (fi)
CA (1) CA1076111A (fi)
CH (1) CH630920A5 (fi)
CS (1) CS191181B2 (fi)
DD (1) DD128178A5 (fi)
DE (1) DE2649116A1 (fi)
DK (1) DK142324B (fi)
EG (1) EG12280A (fi)
ES (2) ES452971A1 (fi)
FI (1) FI62088C (fi)
FR (1) FR2330404A1 (fi)
GB (1) GB1562800A (fi)
HU (1) HU177422B (fi)
IL (1) IL50816A (fi)
IN (1) IN144289B (fi)
MX (1) MX4284E (fi)
NL (1) NL7612187A (fi)
NO (1) NO146470C (fi)
PL (2) PL118308B1 (fi)
PT (1) PT65787B (fi)
RO (2) RO77294A (fi)
SE (1) SE7612260L (fi)
SU (2) SU667137A3 (fi)
YU (1) YU269176A (fi)
ZA (1) ZA766620B (fi)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1185601A (en) * 1981-02-27 1985-04-16 Walter Hunkeler Imidazodiazepines
DE3435973A1 (de) * 1984-10-01 1986-04-10 Boehringer Ingelheim KG, 6507 Ingelheim Diazepine enthaltende pharmazeutische zusammensetzungen mit paf-antagonistischer wirkung
US4798896A (en) * 1988-01-19 1989-01-17 American Home Products Corporation Antipsychotic gamma-carboline N-oxides
US8541407B2 (en) 2010-03-31 2013-09-24 Arqule, Inc. Substituted benzo-pyrido-triazolo-diazepine compounds
AR084070A1 (es) 2010-12-02 2013-04-17 Constellation Pharmaceuticals Inc Inhibidores del bromodominio y usos de los mismos
US9249161B2 (en) 2010-12-02 2016-02-02 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
EP2705039B1 (en) 2011-05-04 2017-07-26 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
EP2721031B1 (en) 2011-06-17 2016-01-20 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
WO2013184878A1 (en) 2012-06-06 2013-12-12 Constellation Pharmaceuticals, Inc. Benzo [b] isoxazoloazepine bromodomain inhibitors and uses thereof
TWI602820B (zh) 2012-06-06 2017-10-21 星宿藥物公司 溴域抑制劑及其用途
DK3157928T3 (da) 2014-06-20 2019-05-20 Constellation Pharmaceuticals Inc Krystallinske former af 2-((4s)-6-(4-chlorphenyl)-1-methyl-4h-benzo[c]isoxazolo[4,5-e]azepin-4-yl)acetamid

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT327917B (de) * 1973-04-12 1976-02-25 Degussa Verfahren zur herstellung von neuen 5-aryl-pyrido- (b-6,7) -1,4-diazepinen und deren salzen
US4039551A (en) * 1976-03-15 1977-08-02 The Upjohn Company 1-[(Hydroxyamino)methyl]-6-aryl-4H-s-triazolo[4,3-a][1,4]benzodiazepines

Also Published As

Publication number Publication date
PL113803B1 (en) 1981-01-31
NO763739L (fi) 1977-05-05
JPS5259194A (en) 1977-05-16
ATA837275A (de) 1978-10-15
RO70245A (ro) 1981-06-30
AR216915A1 (es) 1980-02-15
CH630920A5 (de) 1982-07-15
RO77294A (ro) 1982-09-09
BE847952A (fr) 1977-05-03
IL50816A0 (en) 1977-01-31
ES452971A1 (es) 1978-10-16
NO146470B (no) 1982-06-28
PL193439A1 (pl) 1979-07-16
AR217814A1 (es) 1980-04-30
FR2330404B1 (fi) 1979-07-20
FI763158A (fi) 1977-05-05
IN144289B (fi) 1978-04-22
AU1931176A (en) 1978-05-11
YU269176A (en) 1983-02-28
DK142324B (da) 1980-10-13
SU676165A3 (ru) 1979-07-25
ES452969A1 (es) 1977-11-16
DE2649116A1 (de) 1977-05-18
FR2330404A1 (fr) 1977-06-03
FI62088C (fi) 1982-11-10
AT350056B (de) 1979-05-10
NO146470C (no) 1982-10-06
PL118308B1 (en) 1981-09-30
DK497076A (fi) 1977-05-05
CA1076111A (en) 1980-04-22
DK142324C (fi) 1981-03-02
SE7612260L (sv) 1977-05-05
AU504228B2 (en) 1979-10-04
JPS5831351B2 (ja) 1983-07-05
US4110455A (en) 1978-08-29
FI62088B (fi) 1982-07-30
MX4284E (es) 1982-03-12
SU667137A3 (ru) 1979-06-05
PT65787B (de) 1978-05-10
PT65787A (de) 1976-12-01
HU177422B (en) 1981-10-28
IL50816A (en) 1980-09-16
EG12280A (en) 1978-12-31
CS191181B2 (en) 1979-06-29
DD128178A5 (de) 1977-11-02
AR216916A1 (es) 1980-02-15
NL7612187A (nl) 1977-05-06
GB1562800A (en) 1980-03-19

Similar Documents

Publication Publication Date Title
JPS51143459A (en) Rotary chair
IL49701A (en) 3-amino-4-deoxo-4-imino rifamycin derivatives and their preparation
ZA766620B (en) New 6-aryl-s-triazolo(4,3-a)-pyrido(2,3-f)-1,4-diazepines their preparations and their use
SG61182G (en) Indolo(2,3-a)quinolizidines,preparation and therapeutic use
IL49516A (en) 3-amino-4-deoxo-4-imino and amino-rifamycins and their preparation
IL50080A0 (en) New azabicycloheptanes and their preparation
IL58505A0 (en) 16,16-disubstituted androst-5-ene derivatives and their preparation
PH12281A (en) 1,3,8-triazaspiro(4,5)decan-4-one derivatives and composition containing them
JPS51138667A (en) Anthraquinoneebissamizine and preparation*
IL51092A0 (en) Naphthyridine derivatives and their preparation
IL49606A (en) Imidazo rifamycin derivatives and their preparation
JPS51143630A (en) Nnbenzyll2* 22dimethoxyyacetamide and preparation
IL51853A (en) 1,2,3,3a-tetrahydro(or 1,2,3,3a,4,5-hexahydro)indolo(3,2,1-de)naphthyridine derivatives,their preparation and pharmaceutical compositions containing them
IL57546A (en) 2-aminooctahydroindolo(2,3-a)quinolizine derivatives,their preparation and their use
JPS5212158A (en) Epoxyandrostane and preparation thereof
IL50820A0 (en) Novel rifamycin derivatives and their preparation
JPS5251364A (en) Thiazolizine derivatives and preparation thereof
JPS51125338A (en) Diphenylether derivatives and preparation thereof
NZ181317A (en) N-tetrazol-5'-yl-1-oxo-1h-pyrimido(1,2-a)quinolin-2-yl-carboxamides
CY1085A (en) 1,8-naphthyridine derivatives
ZA763622B (en) 1-acyl-1,2,3,4-tetrahydro-6-quinolinols and their preparation
JPS51118721A (en) Blocked polyisocianate * its preparation and use
GB1549237A (en) 2,5-dihydrofuron derivatives and their preparation
AU508239B2 (en) 1, 2, 3, 4-Tetrahydrobenzoisoquinolines and their use asanti-Aggressive Agents
JPS5248679A (en) Quinoxarinee1*44dioxides and use